Особенности формирования у взрослых гуморального иммунитета к вирусу Varizella zoster
Диссертация
Первичная У2У-инфекция протекает в виде ветряной оспызаболевания сопровождаемого лихорадкой и характерными везикулярными диссеминированными высыпаниями на коже и слизистой оболочке. В большинстве случаев ветряная оспа имеет благоприятный прогноз, однако, с учетом стабильно высокой заболеваемости (554,8 случаев на 100 000 населения в РФ, 2011) и неврологических и офтальмологических осложнений… Читать ещё >
Содержание
- Список сокращений
Список литературы
- Лавров В.Ф., Казанова А. С., Кузин С. Н., и др. Ветряная оспа и опоясывающий лишай: особенности заболеваемости и клинических проявлений. // Эпидемиология и инфекционные болезни. Актуальные вопросы. 2011. № 3. С. 54−57.
- Лакин Г. Ф. Биометрия. — М.: Высшая школа. 1990.
- Маниатис Т., Фрич Э., Сэмбрук Дж. Методы генетической инженерии. Молекулярное клонирование. — М.: Мир. 1984.
- Эбралидзе Л.К., Ведунова С. Л., Мальцева Н. Н. Выявление низкоавидных IgG-антител перспективный подход в диагностике первичной герпетической инфекции. // Вопросы вирусологии 2004. Т49 № 2 с46−48.
- AdelmannM, Linington С. Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein. Neurochem Res. 1992 Sep-17(9):887−91
- Amlie-Lefond C, Jubelt B. Neurologic manifestations of varicella zoster virus infections. Curr Neurol Neurosci Rep. 2009 Nov-9(6):430−4.
- Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A. Persistence of immunity to live attenuated varicella vaccine in healthy adults. Clin Infect Dis. 2002 Mar 15−34(6):774−9.
- Arduino PG, Porter SR. Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features. //J Oral Pathol Med. 2008, 37(2), p. 107−121.
- Arvin AM. Varicella-zoster virus: overview and clinical manifestations. Semin Dermatol. 1996 Jun-15(2 Suppl l):4−7.
- Ю. Askalan R, Laughlin S, Mayank S. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke. 2001 Jun-32(6): 1257−62.
- Banz K, Wagenpfeil S, Neiss A. The burden of varicella in Germany. Potential risks and economic impact. Eur J Health Econ. 2004 Feb-5(l):46−53.
- Braun KP, Bulder MM, Chabrier S. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain. 2009 Feb-132(Pt 2):544−57.
- Brisson M, Edmunds WJ. Varicella vaccination in England and Wales: cost-utility analysis Arch Dis Child. 2003 Oct-88(10):862−9.
- Brok HP, Boven L, van Meurs M, The human CMV-UL86 peptide 9 811 003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34−56, but lacks the capacity to induce EAE in rhesus monkeys. J Neuroimmunol. 2007 Jan-182(l-2):135−52.
- Civen R, Chaves SS, Jumaan A et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J. 2009 Nov-28(ll):954−9.
- Chiner E, Ballester I, Betlloch I. Varicella-zoster virus pneumonia in an adult population: has mortality decreased? Scand J Infect Dis. 2010 Mar-42(3):215−21.
- Cohen JI, Moskal T, Shapiro M, Purcell RH. Varicella in chimpanzees. J Med Virol 1996- 50: 289−92
- Cohrs RJ, Mehta SK, Schmid DS et al. Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. //J. Med. Virol. 2008. № 80(6). P. 1116−1122.
- Cohrs RJ, Randall J, Smith J. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol 2000- 74: 11 464−71
- Dangond F, Engle E, Yessayan L. Pre-eruptive varicella cerebellitis confirmed by PCR. Pediatr Neurol. 1993 Nov-Dec-9(6):491−3.
- Desmond CP, Gaudieri S, James IR. Viral adaptation to hostimmuneresponses occurs inchronichepatitis B virus (HBV)infection, and adaptation is greatest in HBV e antigen-negative disease. J Virol. 2012 Jan-86(2):l 181−92.
- Devinsky O, Cho ES, Petito CK. Herpes zoster myelitis. Brain. 1991 Jun-114 (Pt 3):1181−96
- Drolet M, Brisson M, Schmader K. Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study. J Pain. 2010 Nov-l 1(11):1211−21.
- Enders G, Miller E, Cradock-Watson J. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 1994 Jun 18−343(8912): 1548−51.
- Engelmann M, Ludwig M. The activity of the hypothalamo-neurohypophysial system in response to acute stressor exposure: neuroendocrine and electrophysiological observations. Stress 7(2):91−6 (2004).
- Engstrom RE Jr, Holland GN, Margolis TP. The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology. 1994 Sep-101(9):1488−502.
- Franco-Paredes C, Bellehemeur T, Merchant A. Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS. AIDS. 2002 May 3- 16(7): 1045−9.
- Fung LW, Lao TT, Suen SS, Chan OK, Lau TK, Ngai KL, Chan PK, Leung TY. Seroprevalence of varicella zoster virus among pregnant women in Hong Kong: comparison with self-reported history. Vaccine. 2011 Oct 26−29(46):8186−8188.
- Gauthier A, Breuer J, Carrington D. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009 Jan-137(l):38−47.
- Gershon AA, Chen J, Gershon MD. A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons. J Infect Dis. 2008 Mar 1- 197 Suppl 2: S61−5.
- Gershon AA, Chen J, Davis L, Latency of Varicella Zoster Virus in Dorsal Root, Cranial, and Enteric Ganglia in Vaccinated Children Trans Am Clin Climatol Assoc. 2012- 123: 17−35
- Gershon AA. The current status of live attenuated varicella vaccine. Arch Virol Suppl. 2001-(17):l-6.
- Gershon AA. Varicella-zoster virus infections Pediatr Rev. 2008 Jan-29(l):5−10
- Gilden DH, Beinlich BR, Rubinstien EM. Varicella-zoster virus myelitis: an expanding spectrum. Neurology. 1994 0ct-44(10): 1818−23.
- Gilden DH, Cohrs RJ, Mahalingam R et al. Neurological disease produced by varicella zoster virus reactivation without rash. //Curr. Top. Microbiol. Immunol. 2010. № 342. P. 243−253.
- Gilden DH, Gesser R, Smith J. Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes. 2001 -23(2): 145−7.
- Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000 Mar 2−342(9):635−45
- Gilden DH, Kleinschmidt-DeMasters BK, Wellish M. Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5−1995 revisited. Neurology. 1996 Dec-47(6): 1441−6
- Gilden D, Mahalingam R, Nagel MA Review: The neurobiology of varicella zoster virus infection. Neuropathol Appl Neurobiol. 2011 Feb 23. doi: 0.1111/j.1365−2990.2011.1 167.x.
- Gilden DH. Varicella zoster virus vasculopathy and disseminated encephalomyelitis. J Neurol Sei. 2002 Mar 30−195(2):99−101.
- Gilden DH, Wright RR, Schneck SA. Zoster sine herpete, a clinical variant. Ann Neurol. 1994 May-35(5):530−3. Review.
- Gold I, Azizi E, Eshel G. Neurogenic bladder due to herpes zoster infection in an infant. Eur J Pediatr. 1989 Feb-148(5):468−9.
- Gray F, Belec L, Lescs MC. Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain. 1994 Oct-l 17 (Pt 5):987−99.
- Grohmann U, Fallarino F, Bianchi R et al. Tryptophan catabolism in nonobese diabetic mice. Adv Exp Med Biol. 2003−527:47−54.
- Grose C. Varicella vaccination of children in the United States: assessment after the first decade 1995−2005.J Clin Virol. 2005 Jun-33(2):89−95
- Guess HA, Broughton DD, Melton LJ 3rd. Population-based studies of varicella complications. Pediatrics. 1986 Oct-78(4 Pt 2):723−7.
- Guex-Crosier Y, Rochat C, Herbort CP. Necrotizing herpetic retinopathies. A spectrum of herpes virus-induced diseases determined by the immune state of the host. Ocul Immunol Inflamm. 1997 Dec-5(4):259−65.
- Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med. 1991 Nov 28−325(22): 1545−50.
- Harpaz R, Ortega-Sanchez IR, Seward JF- Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory
- Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008 Jun 6−57(RR-5):l-30-
- Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, Arvin AM. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med. 2002 Jul 4−347(l):26−34.
- Hayward AR, Buda K, Levin MJ. Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults. Viral Immunol. 1994−7(1):31−6.
- Heininger U, Seward JF. Varicella. Lancet. 2006 Oct 14−368(9544):1365−76. Review
- Hicks LD, Cook-Norris RH, Mendoza N. Family history as a risk factor for herpes zoster: a case-control study. Arch Dermatol. 2008 May-144(5):603−8.
- Higa K, Dan K, Manabe H. Varicella-zoster virus infections during pregnancy: hypothesis concerning the mechanisms of congenital malformations. Obstet Gynecol. 1987 Feb-69(2):214−22. Review
- Holland GN. The progressive outer retinal necrosis syndrome. Int Ophthalmol. 1994−18(3):163−5.
- Hufner K, Derfuss T, Herberger S. Latency of alpha-herpes viruses is accompanied by a chronic inflammation in human trigeminal ganglia but not in dorsal root ganglia. J Neuropathol Exp Neurol 2006- 65: 1022−30
- Insinga RP, Itzler RF, Pellissier JM. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005 Aug-20(8):748−53.
- Jellinek EH, Tulloch WS. Herpes zoster with dysfunction of bladder and anus. Lancet. 1976 Dec 4−2(7997): 1219−22.
- Jones L, Black AP, Malavige GN, Ogg GS. Persistent high frequencies of varicella-zoster virus ORF4 protein-specific CD4+ T cells after primary infection. J Virol. 2006 Oct-80(19):9772−8.
- Jones L, Black AP, Malavige GN, Ogg GS. Phenotypic analysis of human CD4+ T cells specific for immediate-early 63 protein of varicella-zoster virus. Eur J Immunol. 2007 Dec-37(12):3393−403.
- Johnson R, Milbourn PE. Central nervous system manifestations of chickenpox. Can Med Assoc J. 1970 Apr 25−102(8):831−4.
- Junker AK, Tilley P. Varicella-zoster virus antibody avidity and IgG-subclass patterns in children with recurrent chickenpox. J Med Virol. 1994 Jun-43(2):l 19−24.
- Katchanov J, Siebert E, Klingebiel R. Infectious vasculopathy of intracranial large- and medium-sized vessels in neurological intensive care unit: a clinico-radiological study. Neurocrit Care. 2010 Jun-12(3):369−74.
- Kennedy PG, Grinfeld E, Bontems S, Sadzot-Delvaux C. Varicella-zoster virus gene expression in latently infected rat dorsal root ganglia. Virology 2001- 289: 218−23
- Kilgore PE, Kruszon-Moran D, Seward JF. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol. 2003−70 Suppl 1: S111−8.
- Kinchington PR, Turse SE. Molecular basis for a geographic variation of varicella-zoster virus recognized by a peptide antibody. Neurology. 1995 Dec-45(12 Suppl 8):S13−4.
- Kitamura K, Namazue J, Campo-Vera H et al. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB. //Virology. 1986 Feb- 149(1), p 74−82.
- Kneitz RH, Schubert J, Tollmann F A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid. BMC Infect Dis. 2004 Sep 8−4:33
- Krause PR, Klinman DM. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nat Med. 2000 Apr-6(4):451−4.
- LaRussa P, Steinberg SP, Shapiro E, Vazquez M, Gershon AA. Varicella vaccine revisited. Nat Med. 2000 Dec- 6(12): 1299−300.
- Lauer G. Immune Responses to Hepatitis C Virus (HCV) Infection and the Prospects for an Effective HCV Vaccine or Immunotherapies J Infect Dis. (2013) 207 (suppl 1):S7-S12.
- Lewis JM, Nagae Y, Tano Y. Progressive outer retinal necrosis after bone marrow transplantation. Am J Ophthalmol. 1996 Dec-122(6):892−5.
- Liedtke W, Opalka B, Zimmermann CW. Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J Neurol Sci 1993- 116: 6−11
- Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008 Feb- 115(2 Suppl):S3−12. Review
- L’Huillier AG, Ferry T, Courvoisier DS Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity*.HIV Med. 2012 Jan-13(l):54−61
- Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010 Mar 9−74(10):792−7.
- Linnemann CC Jr, Alvira MM. Pathogenesis of varicella-zoster angiitis in the CNS. Arch Neurol. 1980 Apr-37(4):239−40.
- Ludwig B, Kraus FB, Allwinn R, Keim S, Doerr HW, Buxbaum S Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination. Infection. 2006 Aug-34(4):222−6.
- Mahalingam R, Traina-Dorge V, Wellish M et al. Simian varicella virus reactivation in cynomolgus monkeys. //Virology. 2007. Vol. 10. № 368(1). P.50−59.
- Mandelbrot L. Fetal varicella diagnosis, management, and outcome. Prenat Diagn. 2012 Jun-32(6):511−8
- Mayberg MR, Langer RS, Zervas NT. Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science. 1981 Jul 10−213(4504):228−30.
- Mayberg MR, Zervas NT, Moscowitz MA. Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol 1984- 223: 46−56
- Mehta SK, Cohrs RJ, Forghani B. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol. 2004 Jan-72(l): 174−9.
- Mendieta C, Miranda J, Brunei LI. Alveolar bone necrosis and tooth exfoliation following herpes zoster infection: a review of the literature and case report. J Periodontol. 2005 Jan-76(l): 148−53. Review
- Menerath JM, Gerard M, Laurichesse H. Bilateral acute retinal necrosis in a patient with acquired immunodeficiency syndrome. J Fr Ophthalmol. 1995−18:625−33.
- Michalik DE, Steinberg SP, Larussa PS, Edwards KM, Wright PF, Arvin AM, Gans HA, Gershon AA. Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis. 2008 Apr l-197(7):944−9.
- Minarovits J, Gonczol E, Valyi-Nagy T. Latency Strategies of Herpesviruses. Springier, NewYork, 2007 300 p.
- Moffat JF, Stein MD, Kaneshima H, Arvin AM. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J Virol 1995- 69: 5236−42
- Mohsen AH, McKendrick M. Varicella pneumonia in adults. Eur Respir J. 2003 May-21(5):886−91. Review
- Nagel MA, Choe A, Traktinskiy I, Cordery-Cotter R, Gilden D, Cohrs RJ. Varicella-zoster virus transcriptome in latently infected human ganglia. J Virol. 2011 Mar-85(5):2276−87. Epub 2010 Dec 22.
- Natoli S, Ciotti M, Paba P, Testore GP, Palmieri G, Orlandi A, Sabato AF, Leonardis F. A novel mutation of varicella-zoster virus associated to fatal hepatitis. J Clin Virol. 2006 Sep-37(l):72−4.
- Ogunjimi B, Smits E, Hens N, Hens A, Lenders K, Ieven M, Van Tendeloo V, Van Damme P, Beutels P. Exploring the impact of exposure to primary varicella in children on varicella-zoster virusimmunityof parents. Viral Immunol. 2011 Apr-24(2):151−7.
- Ou D, Mitchell LA, Metzger DL, Gillam S, Tingle AJ Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinantsrecognised by T cells of patients with type I diabetes mellitus. Diabetologia. 2000 Jun-43(6):750−62
- Oxman MN, Levin MJ, Johnson GR. Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005 Jun 2−352(22):2271−84
- Patterson-Bartlett J, Levin MJ, Lang N. Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine. Vaccine 2007- 25: 7087−93
- Richard A. Santos, Padilla J.A., Hatfield C., Grose C. Antigenic variation of varicella zoster virus Fc receptor gE: loss of a major B cell epitope in the ectodomain. Virology. 1998 Sep 15−249(1):21−31
- Rodriguez-Fanjul X, Noguera A, Vicente A. Herpes zoster in healthy infants and toddlers after perinatal exposure to varicella-zoster virus: a case series and review of the literature. Pediatr Infect Dis J. 2010 Jun — 29(6):574−6.
- Roush SW, Murphy TV- Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007 Nov 14−298(18):2155−63.
- Sadzot-Delvaux C, Merville-Louis MP, Delree P, Marc P, Piette J, Moonen G, Rentier B. An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. JNeurosci Res 1990- 26: 83−9
- Saito K, Moskowitz MA. Contributions from the upper cervical dorsal roots and trigeminal ganglia to the feline circle of Willis. Stroke. 1989 Apr- 20(4):524−526.
- Schwarcz R, Rassoulpour A, Wu HQ, Increased cortical kynurenate content in schizophrenia. Biol Psychiatry. 2001 Oct 1−50(7):521−30
- Schimemann S, Mainka C, Wolff MH. Subclinical reactivation of varicella-zoster virus in immunocompromised and immunocompetent individuals. //Intervirology. 1998. № 41(2−3). P. 98−102.
- Sperber SJ, Smith BV, Hayden FG. Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine. Antiviral Res. 1992 Mar- 17(3):213−22.
- Strangfeld A, Listing J, Herzer P Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA. 2009 Feb 18−301(7):737−44.
- Sugita S, Takase H, Kawaguchi T Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007 Apr-Jun-27(2−3):87−95.
- Sutradhar SC, Wang WW, Schlienger K, Stek JE, Xu J, Chan IS, Silber JL. Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or older. Clin Vaccine Immunol. 2009 May- 16(5):646−52.
- Swami M 2011 HIV-1 adaptation to NK-cell-mediated immune pressure Nature Medicine 1059 (2011)
- Taguchi T, Ueda S, Kudo T. Ramsay-Hunt syndrome. J Infect. 2010 Dec 23.
- Takahashi M, Asano Y, Kamiya H, Baba K, Ozaki T, Otsuka T, Yamanishi K. Development of varicella vaccine J Infect Dis. 2008 Mar 1−197 Suppl 2: S41−44.
- Terada K, Niizuma T, Yagi Y, Miyashima H, Kataoka N, Sadahiro T. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination. J Med Virol. 2000 Sep-62(l):46−51.
- Tipples G A., Gwen M. Stephens, Chris Sherlock, Margrit Bowler, Benny Hoy, Darrel Cook, and Charles Grose New Variant of Varicella-Zoster Virus Emerg Infect Dis. 2002 December- 8(12): 1504−1505.
- Thomas JE, Howard FM Jr. Segmental zoster paresis—a disease profile. Neurology. 1972 May-22(5):459−66.
- Thompson WS, Culbertson WW, Smiddy WE,. Acute retinal necrosis caused by reactivation of herpes simplex virus type 2. Am J Ophthalmol. 1994 Aug 15−118(2):205−11.
- Uchakin PN, Parish DC, Dane FC Fatigue in medical residents leads to reactivation of herpes virus latency. Interdiscip Perspect Infect Dis. 2011−2011:571 340
- Vafai A, Wroblewska Z, Graf L. Antigenic cross-reaction between a varicella-zoster virus nucleocapsidprotein encoded by gene 40 and a herpes simplex virus nucleocapsid protein. //Virus Research 1990, Vol. 15, N 2, p. 163— 174.
- Vena GA, Apruzzi D, Vestita M, Calvario A, Foti C, Cassano N. Zoster. «almost». sine herpete: diagnostic utility of real time-polymerase chain reaction. New Microbiol. 2010 0ct-33(4):409−10.
- Vendrell JP, Segondy M, Ducos J, Reynes J, Huguet MF, Nicolas JC, Serre A. Clin Exp Immunol. 1991 Feb-83(2): 197−202. Analysis of the spontaneous in vitro anti-HIV-1 antibody secretion by peripheral blood mononuclear cells in HIV-1 infection.
- Volvoikar P, Patil S, Dinkar A. Tooth exfoliation, osteonecrosis and neuralgia following herpes zoster of trigeminal nerve. Indian J Dent Res. 2002 Jan-Mar- 13(1): 11 -4. Review.
- Watson CP, Deck JH, Morshead C. Post-herpetic neuralgia: further postmortem studies of cases with and without pain.Pain. 1991 Feb-44(2):105−17.
- Wirgart BZ, Estrada V, Jackson W, Linde A, Grose C. A novel varicella-zoster virus gE mutation discovered in two Swedish isolates. J Clin Virol. 2006 Oct-37(2):134−6.
- Whitley RJ. Therapeutic approaches to varicella-zoster virus infections. J Infect Dis. 1992 Aug-166 Suppl l: S51−7. Review.
- Wroblewska Z, Valyi-Nagy T, Otte J, Dillner A, Jackson A, Sole DP, Fraser NW. A mouse model for varicella-zoster virus latency. Microb Pathog 1993- 15: 141−51
- Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. //JAMA 2006- N 296 (8), p:964−973.
- Yamanishi K. Molecular analysis of the Oka vaccine strain of varicella-zoster virus. J Infect Dis. 2008 Mar 1−197 Suppl 2: S45−8.
- Zerboni L Berarducci B, Rajamani J et al. Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis. // J. Virol. 2011. Jan-85(l):98−111.